Neoadjuvant treatment for invasive bladder cancer: is it worthwhile?

Control group and maintenance treatment with bacillus Calmette-Guerin for carcinoma in situ and/or high grade bladder tumors.

The Journal of urology·2001

Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001

TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy for muscle-invasive bladder cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·1999

Results of a European comparative randomized study comparing oral bropirimine versus intravesical BCG treatment in BCG-naive patients with carcinoma in situ of the urinary bladder. European Bropirimine Study Group.

European urology·1999

Radical transurethral resection and chemotherapy in the treatment of muscle-invasive bladder cancer: a long-term follow-up.

BJU international·1999

Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of Cancer.

The Prostate·1999

Unusual case of Munchausen's syndrome: factitious vesical lithiasis.

Acta urologica Belgica·1999

Ductal ("endometrioid") adenocarcinoma of the prostate.

Acta urologica Belgica·1999

[Conservative treatment of stage III kidney injuries].

Acta urologica Belgica·1999

Endoscopic treatment of complete posterior urethral obliteration.

Acta urologica Belgica·1999

Erratum: Defining the optimal imaging time point for fluorescence-lifetime-based tumor identification using the non-targeting near-infrared dye indocyanine green and post-processed high-dynamic-range images: errata.

Biomedical optics express·2026

Low-Dose Radiotherapy for Benign Achillodynia: A Single Center Experience With Prospective Follow-Up.

Cureus·2026

Microfluidic Isolation of Aptamers for Intracellular Measurement of Radio-Responsive Proteins.

Radiation (Multidisciplinary Digital Publishing Institute)·2026

Microenvironmental remodeling in FLASH radiotherapy.

Frontiers in cell and developmental biology·2026

Open Boari Flap Ureteroneocystostomy in a Radiated Pelvis: A Durable Solution for Complex Distal Ureteric Strictures.

Annals of African medicine·2026

Definitive carbon ion radiotherapy for thoracic bone and soft tissue sarcoma.

BMC cancer·2026

Related Experiment Videos

Neoadjuvant treatment for invasive bladder cancer: is it worthwhile?

Related Concept Videos

Control group and maintenance treatment with bacillus Calmette-Guerin for carcinoma in situ and/or high grade bladder tumors.

Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group.

TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy for muscle-invasive bladder cancer.

Results of a European comparative randomized study comparing oral bropirimine versus intravesical BCG treatment in BCG-naive patients with carcinoma in situ of the urinary bladder. European Bropirimine Study Group.

Radical transurethral resection and chemotherapy in the treatment of muscle-invasive bladder cancer: a long-term follow-up.

Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of Cancer.

Unusual case of Munchausen's syndrome: factitious vesical lithiasis.

Ductal ("endometrioid") adenocarcinoma of the prostate.

[Conservative treatment of stage III kidney injuries].

Endoscopic treatment of complete posterior urethral obliteration.

Erratum: Defining the optimal imaging time point for fluorescence-lifetime-based tumor identification using the non-targeting near-infrared dye indocyanine green and post-processed high-dynamic-range images: errata.

Low-Dose Radiotherapy for Benign Achillodynia: A Single Center Experience With Prospective Follow-Up.

Microfluidic Isolation of Aptamers for Intracellular Measurement of Radio-Responsive Proteins.

Microenvironmental remodeling in FLASH radiotherapy.

Open Boari Flap Ureteroneocystostomy in a Radiated Pelvis: A Durable Solution for Complex Distal Ureteric Strictures.

Definitive carbon ion radiotherapy for thoracic bone and soft tissue sarcoma.

Related Experiment Videos

Neoadjuvant treatment for invasive bladder cancer: is it worthwhile?

Related Concept Videos

Related Articles